Genetic Signatures Ltd (GSS) — Cash Flow-to-Debt Ratio
Genetic Signatures Ltd (GSS) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of AU$-349.00K could theoretically repay 0% of its total liabilities (AU$4.95 Million) in one year. See GSS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genetic Signatures Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Genetic Signatures Ltd across 13 annual periods. For the full cash flow conversion analysis, see Genetic Signatures Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Genetic Signatures Ltd (2013–2025)
Year-by-year debt coverage analysis for Genetic Signatures Ltd. Check earnings quality score of Genetic Signatures Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.71x | AU$-12.29 Million | AU$4.54 Million | ▼ -65.5% |
| 2024 | -1.64x | AU$-10.12 Million | AU$6.18 Million | ▲ +19.0% |
| 2023 | -2.02x | AU$-12.45 Million | AU$6.16 Million | ▼ -199.9% |
| 2022 | 2.02x | AU$9.81 Million | AU$4.85 Million | ▲ +126.8% |
| 2021 | 0.89x | AU$4.20 Million | AU$4.71 Million | ▲ +135.5% |
| 2020 | -2.51x | AU$-9.49 Million | AU$3.79 Million | ▼ -72.5% |
| 2019 | -1.45x | AU$-2.27 Million | AU$1.56 Million | ▲ +52.4% |
| 2018 | -3.05x | AU$-3.69 Million | AU$1.21 Million | ▼ -41.3% |
| 2017 | -2.16x | AU$-2.57 Million | AU$1.19 Million | ▼ -7.9% |
| 2016 | -2.00x | AU$-2.57 Million | AU$1.28 Million | ▲ +46.7% |
| 2015 | -3.76x | AU$-2.80 Million | AU$743.14K | ▼ -2.9% |
| 2014 | -3.66x | AU$-1.35 Million | AU$370.48K | ▼ -1203.5% |
| 2013 | -0.28x | AU$-1.19 Million | AU$4.23 Million | — |